| Primary |
| Drug Use For Unknown Indication |
27.1% |
| Cytomegalovirus Gastrointestinal Infection |
20.3% |
| Cytomegalovirus Infection |
12.7% |
| Immunosuppression |
8.5% |
| Cytomegalovirus Gastritis |
5.1% |
| Heart Transplant |
3.4% |
| Pneumonia |
3.4% |
| Fungal Infection |
2.5% |
| Hiv Infection |
2.5% |
| Transplant Rejection |
2.5% |
| Aplasia Pure Red Cell |
1.7% |
| Bone Marrow Transplant |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Renal Failure |
1.7% |
| Bacterial Infection |
0.8% |
| Congenital Cytomegalovirus Infection |
0.8% |
| Graft Versus Host Disease |
0.8% |
| Hypertension |
0.8% |
| Hypothyroidism |
0.8% |
| Leukopenia |
0.8% |
|
| Renal Failure |
25.0% |
| Thrombocytopenia |
11.1% |
| Deafness |
6.9% |
| Sepsis |
5.6% |
| Thrombotic Thrombocytopenic Purpura |
5.6% |
| Death |
4.2% |
| Pericarditis |
4.2% |
| Tachypnoea |
4.2% |
| Ventricular Fibrillation |
4.2% |
| Ventricular Hypertrophy |
4.2% |
| Cytomegalovirus Gastritis |
2.8% |
| Deafness Neurosensory |
2.8% |
| Hypotension |
2.8% |
| Peritonitis |
2.8% |
| Rectal Haemorrhage |
2.8% |
| Septic Shock |
2.8% |
| Supraventricular Tachycardia |
2.8% |
| Tinnitus |
2.8% |
| Acute Pulmonary Oedema |
1.4% |
| Acute Respiratory Distress Syndrome |
1.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
31.4% |
| Cytomegalovirus Gastrointestinal Infection |
15.2% |
| Renal Transplant |
9.5% |
| Congenital Cytomegalovirus Infection |
8.6% |
| Cytomegalovirus Infection |
6.7% |
| Encephalitis Herpes |
5.7% |
| Immunosuppression |
3.8% |
| Pneumonia |
3.8% |
| Transplant |
2.9% |
| Aplasia Pure Red Cell |
1.9% |
| Bone Marrow Transplant |
1.9% |
| Mycosis Fungoides |
1.9% |
| Off Label Use |
1.9% |
| Bacterial Infection |
1.0% |
| Cytomegalovirus Gastritis |
1.0% |
| Cytomegalovirus Serology |
1.0% |
| Fungal Infection |
1.0% |
| Graft Versus Host Disease |
1.0% |
|
| Renal Failure |
17.0% |
| Thrombocytopenia |
11.3% |
| Pyrexia |
7.5% |
| Deafness |
5.7% |
| Product Name Confusion |
5.7% |
| Thrombotic Thrombocytopenic Purpura |
5.7% |
| Torsade De Pointes |
5.7% |
| Troponin Increased |
5.7% |
| Ventricular Hypertrophy |
5.7% |
| Deafness Neurosensory |
3.8% |
| Pericarditis |
3.8% |
| Peritonitis |
3.8% |
| Sepsis |
3.8% |
| Tachypnoea |
3.8% |
| Acute Pulmonary Oedema |
1.9% |
| Cytomegalovirus Gastritis |
1.9% |
| Death |
1.9% |
| Pancreatitis |
1.9% |
| Poor Venous Access |
1.9% |
| Renal Failure Acute |
1.9% |
|
| Concomitant |
| Prophylaxis Against Renal Transplant Rejection |
11.1% |
| Prophylaxis |
9.0% |
| Liver Transplant |
8.5% |
| Product Used For Unknown Indication |
7.6% |
| Prophylaxis Against Transplant Rejection |
7.3% |
| Vitamin Supplementation |
6.9% |
| Drug Use For Unknown Indication |
5.7% |
| B-cell Lymphoma |
5.2% |
| Immunosuppression |
4.7% |
| Mineral Supplementation |
3.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.8% |
| Cytomegalovirus Infection |
3.6% |
| Pneumonia |
3.6% |
| Premedication |
3.3% |
| Prophylaxis Of Nausea And Vomiting |
3.3% |
| Antiretroviral Therapy |
2.8% |
| Behcet's Syndrome |
2.8% |
| Gastric Ulcer |
2.8% |
| Aspergillosis |
2.1% |
| Chemotherapy |
1.9% |
|
| Systemic Inflammatory Response Syndrome |
13.1% |
| Urinary Tract Infection |
9.8% |
| Thrombotic Thrombocytopenic Purpura |
8.2% |
| Urosepsis |
8.2% |
| Perirenal Haematoma |
6.6% |
| Pneumonia Pseudomonas Aeruginosa |
6.6% |
| Parkinson's Disease |
4.9% |
| Pneumonia Fungal |
4.9% |
| Pyrexia |
4.9% |
| Leukopenia |
3.3% |
| Neutropenia |
3.3% |
| Pancreatitis |
3.3% |
| Renal Cyst |
3.3% |
| Thoracic Cavity Drainage |
3.3% |
| Thrombotic Microangiopathy |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Tuberculosis |
3.3% |
| Ureteric Obstruction |
3.3% |
| Bradycardia |
1.6% |
| Drug Interaction |
1.6% |
|
| Interacting |
|
|
